Selenoprotein T Promotes Proliferation and G1-to-S Transition in SK-N-SH Cells: Implications in Parkinson's Disease.

BACKGROUND Selenium is prioritized to the brain mainly for selenoprotein expression. Selenoprotein T (SELENOT) protects dopaminergic, postmitotic neurons in a mouse model of Parkinson's disease (PD). OBJECTIVE We hypothesized a proliferative role of SELENOT in neural cells. METHODS To assess SELENOT status in PD, sedated male C57BL/6 mice at 10-12 wk of age were injected with 6-hydroxydopamine in neurons, and human peripheral blood mononuclear cells were isolated from 9 healthy subjects (56% men, 68-y-old) and 11 subjects with PD (64% men, 63-y-old). Dopaminergic neural progenitor-like SK-N-SH cells with transient SELENOT overexpression or knockdown were maintained in the presence or absence of the antioxidant N-acetyl-l-cysteine and the calcium channel blocker nimodipine. Cell cycle, proliferation, and signaling parameters were determined by immunoblotting, qPCR, and flow cytometry. RESULTS SELENOT mRNA abundance was increased (P < 0.05) in SK-N-SH cells treated with 1-methyl-4-phenylpyridinium iodide (3.5-fold) and peripheral blood mononuclear cells from PD patients (1.6-fold). Likewise, SELENOT was expressed in tyrosine hydroxylase-positive dopaminergic neurons of 6-hydroxydopamine-injected mice. Knockdown of SELENOT in SK-N-SH cells suppressed (54%; P < 0.05) 5-ethynyl-2'-deoxyuridine incorporation but induced (17-47%; P < 0.05) annexin V-positive cells, CASPASE-3 cleavage, and G1/S cell cycle arrest. SELENOT knockdown and overexpression increased (88-120%; P < 0.05) and reduced (37-42%; P < 0.05) both forkhead box O3 and p27, but reduced (51%; P < 0.05) and increased (1.2-fold; P < 0.05) cyclin-dependent kinase 4 protein abundance, respectively. These protein changes were diminished by nimodipine or N-acetyl-l-cysteine treatment (24 h) at steady-state levels. While the N-acetyl-l-cysteine treatment did not influence the reduction in the amount of calcium (13%; P < 0.05) by SELENOT knockdown, the nimodipine treatment reversed the decreased amount of reactive oxygen species (33%; P < 0.05) by SELENOT overexpression. CONCLUSIONS These cellular and mouse data link SELENOT to neural proliferation, expanding our understanding of selenium protection in PD.

[1]  Xiong Zhang,et al.  Prioritized brain selenium retention and selenoprotein expression: Nutritional insights into Parkinson’s disease , 2019, Mechanisms of Ageing and Development.

[2]  Y. Anouar,et al.  AMPK Activation of PGC-1α/NRF-1-Dependent SELENOT Gene Transcription Promotes PACAP-Induced Neuroendocrine Cell Differentiation Through Tolerance to Oxidative Stress , 2018, Molecular Neurobiology.

[3]  Yong Cheng,et al.  Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis , 2018, Front. Mol. Neurosci..

[4]  M. Martina,et al.  Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1 , 2018, The Journal of clinical investigation.

[5]  Huawei Zeng,et al.  Analyses of Selenotranscriptomes and Selenium Concentrations in Response to Dietary Selenium Deficiency and Age Reveal Common and Distinct Patterns by Tissue and Sex in Telomere-Dysfunctional Mice. , 2017, The Journal of nutrition.

[6]  M. Landry,et al.  Selenoprotein T is a novel OST subunit that regulates UPR signaling and hormone secretion , 2017, EMBO reports.

[7]  Lili Zhou,et al.  Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson’s Disease , 2017, Front. Cell. Neurosci..

[8]  M. Hermann,et al.  C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy , 2017, Molecular Cancer.

[9]  Y. Anouar,et al.  Selenoprotein T Deficiency Leads to Neurodevelopmental Abnormalities and Hyperactive Behavior in Mice , 2016, Molecular Neurobiology.

[10]  Kaiyu Qian,et al.  Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways , 2016, Molecules.

[11]  Song-Fang Chen,et al.  Selenotranscriptomic Analyses Identify Signature Selenoproteins in Brain Regions in a Mouse Model of Parkinson’s Disease , 2016, PloS one.

[12]  Takamasa Ishii,et al.  Endogenous reactive oxygen species cause astrocyte defects and neuronal dysfunctions in the hippocampus: a new model for aging brain , 2016, Aging cell.

[13]  E. Lam,et al.  Activation of autophagy by FOXO3 regulates redox homeostasis during osteogenic differentiation , 2016, Autophagy.

[14]  Xiong Zhang,et al.  Redox-sensitive MAPK and Notch3 regulate fibroblast differentiation and activation: a dual role of ERK1/2 , 2016, Oncotarget.

[15]  Abdallah Hamieh,et al.  Selenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease , 2016, Antioxidants & redox signaling.

[16]  M. Berry,et al.  Competition between the Brain and Testes under Selenium-Compromised Conditions: Insight into Sex Differences in Selenium Metabolism and Risk of Neurodevelopmental Disease , 2015, The Journal of Neuroscience.

[17]  K. Hasegawa,et al.  Cineradiographic analysis of respiratory movements in a mouse model for early Parkinson's disease , 2015, Respiratory Physiology & Neurobiology.

[18]  A. Lang,et al.  Parkinson's disease , 2015, The Lancet.

[19]  O. Krizanova,et al.  Calcium and ROS: A mutual interplay , 2015, Redox biology.

[20]  M. Boxem,et al.  Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells , 2015, Nature Communications.

[21]  Shane J. Neph,et al.  A comparative encyclopedia of DNA elements in the mouse genome , 2014, Nature.

[22]  G. Maity,et al.  CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27Kip1 via Skp2 and FOXO3a regulation , 2014, Oncogene.

[23]  V. Winfrey,et al.  Selenoprotein P and apolipoprotein E receptor‐2 interact at the blood‐brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  V. Gladyshev,et al.  Selenoproteins: molecular pathways and physiological roles. , 2014, Physiological reviews.

[25]  L. Chavatte,et al.  Interplay between Selenium Levels, Selenoprotein Expression, and Replicative Senescence in WI-38 Human Fibroblasts* , 2014, The Journal of Biological Chemistry.

[26]  F. Pattou,et al.  The PACAP-regulated gene selenoprotein T is abundantly expressed in mouse and human β-cells and its targeted inactivation impairs glucose tolerance. , 2013, Endocrinology.

[27]  L. White,et al.  Changes in selenoprotein P in substantia nigra and putamen in Parkinson's disease. , 2012, Journal of Parkinson's disease.

[28]  P. Pinton,et al.  Mitochondrial Ca2+ and apoptosis , 2012, Cell calcium.

[29]  Joseph H. Callicott,et al.  Interplay between DISC1 and GABA Signaling Regulates Neurogenesis in Mice and Risk for Schizophrenia , 2012, Cell.

[30]  R. Sunde,et al.  Selenium regulation of the selenoprotein and nonselenoprotein transcriptomes in rodents. , 2011, Advances in nutrition.

[31]  A. Manning-Boğ,et al.  Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain , 2011, Molecular Neurodegeneration.

[32]  Prema Subbarayal,et al.  Mutation of megalin leads to urinary loss of selenoprotein P and selenium deficiency in serum, liver, kidneys and brain. , 2010, The Biochemical journal.

[33]  B. Carlson,et al.  Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  J. Lesage,et al.  Selenoprotein T is a PACAP‐regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  Markus Brielmeier,et al.  The Role of Thioredoxin Reductases in Brain Development , 2008, PloS one.

[36]  T. Abel,et al.  Neurodegeneration in Mice Resulting From Loss of Functional Selenoprotein P or Its Receptor Apolipoprotein E Receptor 2 , 2008, Journal of neuropathology and experimental neurology.

[37]  S. Blain,et al.  Differential Modification of p27Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity , 2007, Molecular and Cellular Biology.

[38]  E. Weeber,et al.  Deletion of Apolipoprotein E Receptor-2 in Mice Lowers Brain Selenium and Causes Severe Neurological Dysfunction and Death When a Low-Selenium Diet Is Fed , 2007, The Journal of Neuroscience.

[39]  N. Grishin,et al.  SelT, SelW, SelH, and Rdx12: genomics and molecular insights into the functions of selenoproteins of a novel thioredoxin-like family. , 2007, Biochemistry.

[40]  Akihiro Nakayama,et al.  All regions of mouse brain are dependent on selenoprotein P for maintenance of selenium. , 2007, The Journal of nutrition.

[41]  Richard W. Kriwacki,et al.  Cdk-Inhibitory Activity and Stability of p27 Kip1 Are Directly Regulated by Oncogenic Tyrosine Kinases , 2007, Cell.

[42]  Judith Campisi,et al.  Cancer and ageing: rival demons? , 2003, Nature Reviews Cancer.

[43]  E. Lam,et al.  Cell Cycle Inhibition by FoxO Forkhead Transcription Factors Involves Downregulation of Cyclin D , 2002, Molecular and Cellular Biology.

[44]  Tullio Pozzan,et al.  The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide‐induced apoptosis: significance for the molecular mechanism of Bcl‐2 action , 2001, The EMBO journal.

[45]  R. Medema,et al.  AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 , 2000, Nature.

[46]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[47]  R. Sunde,et al.  Selenium regulation of classical glutathione peroxidase expression requires the 3' untranslated region in Chinese hamster ovary cells. , 1997, The Journal of nutrition.

[48]  W. Sadee,et al.  Expression of neurotransmitter receptors and myc protooncogenes in subclones of a human neuroblastoma cell line. , 1987, Cancer research.